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Abstract
Background: The flagellate protozoan parasite, Trypanosoma cruzi, is a causative agent of Chagas disease that is transmitted
by reduviid bugs to humans. The parasite exists in multiple morphological forms in both vector and host, and cell
differentiation in T. cruzi is tightly associated with stage-specific protein synthesis and degradation. However, the specific
molecular mechanisms responsible for this coordinated cell differentiation are unclear.
Methodology/Principal Findings: The SUMO conjugation system plays an important role in specific protein expression. In T.
cruzi, a subset of SUMOlylated protein candidates and the nuclear localization of SUMO have been shown. Here, we
examined the biological roles of SUMO in T. cruzi. Site-directed mutagenesis analysis of SUMO consensus motifs within T.
cruzi SUMO using a bacterial SUMOylation system revealed that T. cruzi SUMO can polymerize. Indirect fluorescence analysis
using T. cruzi SUMO-specific antibody showed the extra-nuclear localization of SUMO on the flagellum of epimastigote and
metacyclic and bloodstream trypomastigote stages. In the short-flagellate intracellular amastigote, an extra-nuclear
distribution of SUMO is associated with basement of the flagellum and becomes distributed along the flagellum as
amastigote transforms into trypomastigote. We examined the flagellar target protein of SUMO and show that a paraflagellar
rod protein, PFR1, is SUMOylated.
Conclusions: These findings indicate that SUMOylation is associated with flagellar homeostasis throughout the parasite life
cycle, which may play an important role in differentiation of T. cruzi.
Citation: Annoura T, Makiuchi T, Sariego I, Aoki T, Nara T (2012) SUMOylation of Paraflagellar Rod Protein, PFR1, and Its Stage-Specific Localization in
Trypanosoma cruzi. PLoS ONE 7(5): e37183. doi:10.1371/journal.pone.0037183
Editor: Ziyin Li, University of Texas-Houston Medical School, United States of America
Received February 7, 2012; Accepted April 17, 2012; Published May 17, 2012
Copyright:  2012 Annoura et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by grants-in-aid for scientific research Nos. 20790327, 18890188 (to T. Annoura) and 19590436 (to T. Nara), by the 21st
Century COE Research (to T. Annoura, T. Makiuchi and T. Aoki), and by the Foundation of Strategic Research Projects in Private Universities (S0991013; to T. Nara)
from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript. No additional external funding received for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tnara@juntendo.ac.jp
¤a Current address: Leiden Malaria Research Group, Department of Parasitology, Centre for Infectious Diseases, Leiden University Medical Center, Leiden, The
Netherlands
¤b Current address: Department of Parasitic Diseases, National Institute of Infectious Diseases, Tokyo, Japan
¤c Current address: Departamento de Parasitologı ´a, Instituto de Medicina Tropical ‘‘Pedro Kourı ´’’, Habana, Cuba
Introduction
Chagas disease, caused by infection with the parasitic protist,
Trypanosoma cruzi, is one of important neglected tropical diseases
endemic in Central and South America that burdens 16–18
million people with 25,000 of annual deaths. T. cruzi includes
multiple developmental forms in its life cycle. In the insect vector,
triatomine bug, epimastigote proliferates and transforms into
metacyclic trypomastigote, which is transmitted via triatomine
urine and invades inside the human cell [1]. After invasion,
metacyclic trypomastigote transforms into the round-shaped
amastigote, which shorten the flagellum and multiplies continu-
ously until the host cell dies. Prior to the rupture of died cell,
amastigote extends the flagellum and transforms back into
infective bloodstream trypomastigote.
This reciprocal transformation cycle is particularly important
for pathogenesis of Chagas disease because trypomastigote cannot
propagate. Although transformation is accompanied with a variety
of morphological and metabolic changes [2,3], the molecular
mechanisms required for such differentiation and proliferation
remain to be uncovered [4].
Post-translational modifications play an important role in the
functional expression of proteins by altering their stability, activity,
and localization, as well as their ability to interact with other
molecules. SUMO, the small ubiquitin-related modifier, is known
to play an important role in a wide variety of eukaryotic cellular
processes by modifying numerous proteins and modulating their
function and/or activation [5]. SUMO conjugation is essential in
eukaryotes and regulates specific protein expression, often by
antagonizing ubiquitin-mediated protein degradation, and the
downstream effects include cell cycle progression, DNA repair and
stress responses [6,7].
The presence of the SUMO conjugation system in trypanoso-
matid parasites has been recently reported. In T. brucei, SUMO is
essential in cell cycle regulation in procyclic and bloodstream
forms [8]. On the other hand, topoisomerase-II, which accumu-
lates at centromere during prometaphase and is required for
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T. brucei, despite of its regulation via SUMO conjugation in other
eukaryotes [9–11]. Bayona et al. have recently reported the
occurrence of SUMO conjugation in T. cruzi [12]. Proteomic
analysis of the SUMOylated protein-enriched fraction showed that
236 candidate proteins appeared to be SUMOylated. Among
them, metacaspase 3 was found to be a bona fide substrate of
SUMOylation. However, the biological roles of SUMO conjuga-
tion in trypanosomatids are still unclear.
Several SUMOs (SMT3 and human SUMO2 and SUMO3)
can polymerize and become what is known as poly-SUMO via the
N-terminal region of the SUMO consensus motif (y-K-x-D/E,
where y is a hydrophobic residue, K is the lysine conjugated to
SUMO, x is any amino acid, and D and E are acidic residues).
The biological importance of poly-SUMOylation is strongly
implicated in yeast strains lacking poly-SUMO activity [13].
In the present study, we report the occurrence of polymerization
of T. cruzi SUMO and its involvement in the flagellar homeostasis
of the parasite. We show the presence of SUMO consensus motifs
in T. cruzi SUMO and the occurrence of poly-SUMOylation using
a Escherichia coli-based in vivo chimeric SUMOylation system.
Indirect immunofluorescence analysis (IFA) demonstrates the
localization of SUMO in the nucleus in all parasite developmental
stages. In addition, an extra-nuclear localization of SUMO is
associated with the parasite flagellum; in the intracellular
amastigote, SUMO is associated with basement of the flagellum
and becomes clearly distributed along the flagellum as amastigote
transforms into trypomastigote. Analysis using the bacterial
SUMOylation and Western blots of the parasite extracts revealed
that a paraflagellar rod protein, PFR1 is one of SUMOylation
substrates. The physiological roles of T. cruzi SUMO conjugation
in flagellar homeostasis are discussed.
Results
The Occurrence of Poly-Sumoylation In T. Cruzi SUMO
Two SUMO genes, TcSUMOa and TcSUMOb, are present in
the T. cruzi genome sequence database (designated TcSUMOa and
TcSUMOb; Tc00.1047053511661.50 and Tc00.1047053507809.
70, respectively) [14]. The amino acid sequence alignment and the
putative poly-SUMO motifs of various SUMOs are shown in
Fig. 1A. The strength of the predicted poly-SUMO motif was
calculated using SUMOplot
TM Analysis Program (http://www.
abgent.com.cn/doc/sumoplot/login.asp). The predicted probabil-
ity scores for T. cruzi SUMOs are 0.99 and 0.77 for
22VKSE and
45IKCG, respectively. Notably, the presence of poly-SUMO motif
varies among protozoan parasites. The poly-SUMO motif is
present in T. cruzi and L. major SUMOs but absent in T. brucei,
despite of significant conservation of the amino acid sequence in
trypanosomatid SUMOs.
To determine whether the poly-SUMO motifs of T. cruzi
SUMO is SUMOylated, we used an Escherichia coli-based, in vivo
chimeric SUMOylation system [15,16]. This system is able to
detect SUMOylation of heterologous eukaryotic substrate proteins
by conjugation of the human SUMOylation machinery [17]. We
expressed the recombinant TcSUMO tagged with His-V5 at its N-
terminal in E. coli together with human SUMO1 (hSUMO1) and
its modifying enzymes, E1 and E2. In this system, TcSUMO only
serves as a substrate because the expressed TcSUMO is an
inactivated form. We expressed TcSUMO and a series of the site-
directed mutants, of which the putative SUMOylation site, Lys23
or Lys46, was replaced with Arg independently or in combination
(Fig. 1B, K23R, K46R, or K23R/K46R mutant).
Western blot analysis using anti-V5 antibody showed the
multiple bands of 20-, 35-, and 50-kDa in wild type TcSUMO
and K46R mutant (Fig. 1B). Because the recombinant TcSUMO
and hSUMO1 are 20-kDa and 15-kDa proteins, respectively, the
35- and 50-kDa bands corresponded to mono- and di-SUMO1-
conjugated TcSUMO, respectively. In contrast, the K23R and
K23R/K46R mutants showed loss of the 50-kDa band, indicating
loss of SUMOylation by K23R mutation. The 50-kDa band
appeared to correspond to ‘‘di’’-SUMO1-conjugated TcSUMO,
suggesting the occurrence of SUMOylation at least two sites;
however, an additional SUMOylation site was unclear. We
conclude that Lys23 is involved in poly-SUMOylation in this
system.
SUMOylation in the Developmental Stages of T. Cruzi
We examined SUMOylation in different developmental stages
of T. cruzi (Supporting Fig. S1). Western blot analysis using the
anti-TcSUMO antibody was carried out to detect SUMOylated
proteins, which are covalently bound to SUMO between the e-
amino group of lysine of the substrate proteins and the C-terminal
carboxyl group of SUMO. The specificity of anti-TcSUMO
antibody was confirmed by Western blot using the E. coli lysate
expressing recombinant TcSUMO, showing a single band of
expected size.
Numerous bands were detected, consistent with the recent
report [12], in all developmental stages; most bands were common
but several bands were specific to the developmental stages. These
results corroborate previous data [12] that not only SUMOylation
occur in all T. cruzi developmental stages but also some proteins
are specifically SUMOylated within each developmental stage.
Using immunoprecipitation (IP) techniques, we attempted to
isolate SUMOylated parasite proteins in order to determine the
physiological substrates of SUMO conjugation. IP of epimastigote
cell lysates using anti-TcSUMO antibodies followed by Western
blotting showed a strong band at 15 kDa, which corresponds to
TcSUMO monomer; however, we could not detect any substrate
proteins (data not shown).
We suspected that the failure of the detection of SUMOylated
proteins in the parasite lysate might be due to the rapid turnover of
SUMO conjugation. SUMO-specific cleaving cysteine proteases
(SENP, sentrin proteases) is not only responsible for activation of
SUMO, by which a C-terminal GG motif is cleaved off, but also
mediates removal of SUMO from the SUMOylated proteins. To
clarify this, we expressed the recombinant SUMO tagged with N-
terminal FLAG and C-terminal MYC in T. cruzi epimastigotes and
examined the SENP activity of the parasite. We failed to detect the
unprocessed forms of SUMO after immunoprecipitation. Cleav-
age (activation) of the immature SUMO were not inhibited even in
the presence of N-ethyl-maleimide (NEM), a canonical SENP
inhibitor that is an alkylating agent and modifies all cysteine
residues, at high concentrations (Supporting Fig. S2A).
Overexpression of the recombinant SUMO (FLAG-TcSUMO-
MYC) appeared to be toxic to the parasite. This transgenic
parasite did not show the defect of growth, but showed
morphological abnormality, probably due to the physiological
disturbance caused by the excess amount of SUMO (Supporting
Fig. S2B).
Localization of SUMO in T. Cruzi Nucleus and Flagellum
The subcellular localization of SUMO in T. cruzi was examined
by IFA using anti-TcSUMO antibody (Fig. 2). Pre-immune sera,
as well as the antibody fraction depleted of anti-TcSUMO, did not
react with the parasites, confirming the specificity of anti-
TcSUMO antibody (Fig. 2, C1–C4, top row). Strong fluorescence
SUMOylation of a Flagellar Protein in T. cruzi
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developmental stages, consistent with the recent findings [12].
Unexpectedly, the signal was also detected in the flagellum of
both epimastigotes (Fig. 2a–h) and metacyclic trypomastigotes
(Fig. 2i–l). The intensity and pattern of antibody staining in the
nucleus of trypomastigotes was of two types: Type I is
characterized by strong intensity of anti-SUMO staining along
an elongated nucleus (Fig. 2m–p); and Type II is typified by weak
intensity staining around a round nucleus (Fig. 2q–t). 80% of
trypomastigotes examined so far appeared to have type I staining
and the reminder having type II, whereas the flagellum was clearly
and similarly labeled in both types (Fig. 2t).
In intracellular amastigotes, SUMO was also detected in the
nucleus, as well as small ‘dot’-like staining at the basement of the
flagellum (Fig. 2u–y, shown in arrowheads). These results indicate
that SUMO is localized not only in the nucleus but also the
flagellum and strongly suggests that SUMOylation takes place in
both these organelles in T. cruzi.
A Paraflagellar Rod Protein, PFR1, is SUMOylated in T.
Cruzi
To identify the T. cruzi flagellum protein target(s) of SUMOyla-
tion, we screened in silico for flagellum-associated proteins that are
expressed in all developmental stages and possess SUMO
consensus motif. Consequently, we identified a paraflagellar rod
Figure 1. Characterization of T. cruzi SUMO. (A) Multiple alignment of the amino acid sequences of SUMOs of parasitic protists, T. cruzi, L. major,
T. brucei and Plasmodium falciparum, SUMO1 and SUMO3 of human, and SMT3 of Saccharomyces cerevisiae. Gaps are shown as dashes. Shaded amino
acids indicate the putative poly-SUMO motifs. (B) Western blot analysis of poly-SUMOylation of T. cruzi SUMO using an E. coli SUMOylation system.
The recombinant TcSUMO tagged with His-V5 at the N-terminal (Wild) and a series of site-directed mutants were expressed in E. coli in the absence
(2) or presence (+) of human SUMO1 and its modifiers and reacted with anti-V5 antibody. K23, K46, and K23/K46 indicate the mutants lacking the
respective Lys residues.
doi:10.1371/journal.pone.0037183.g001
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37183Figure 2. Localization of SUMO in the life cycle of T. cruzi. Indirect immunofluorescence analysis using anti-TcSUMO antibody of epimastigotes
(Epi; a–h), metacyclic trypomastigotes (MC; i–l), trypomastigotes of Type I (Tryp I; m–p, see text) and Type II (Tryp II; q–t), and amastigotes (Ama; u–y).
The parasite nucleus and kinetoplast were counterstained with Hoechst 33342. As a negative control, epimastigotes were reacted with the labeled
pre-immune serum (C1–C4). Labels are as follows; DIC, differential interference contrast images (left column); TcSUMO, parasites labeled with anti-
TcSUMO antibody (next left); Hoechst, parasites stained with Hoechst 33342 (center right); and Merge, merged images (right). Panel y shows the
magnified image of the inset in panel x. Scale bar=10 mm.
doi:10.1371/journal.pone.0037183.g002
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SUMO consensus motifs (
54LKAE,
136AKME, and
477MKKE; see
Supporting Fig. S3). Interestingly, proteomic analyses revealed the
expression of PFR1 also in the ‘‘short-flagellate’’ amastigotes [18].
In addition, PFR proteins are found to be degraded by proteasome
in T. cruzi [19] and it is important to note that SUMOylated
proteins can serve as substrates for ubiquitin-proteasome degra-
dation.
To examine whether PFR1 is SUMOylated in T. cruzi,w e
generated an antibody raised against a synthetic TcPFR1 peptide.
Western blot analysis of epimastigote cell lysate using anti-PFR1
antibody showed clearly three bands, a strong 70-kDa and weak
85- and 100-kDa bands, which are likely to correspond to the
intact PFR1 and mono- and di-SUMOylated PFR1, respectively
(Fig. 3, lane 1).
We further examined the SUMOylation of PFR1 using an E.
coli-based in vivo chimeric SUMOylation system. Recombinant
PFR1 tagged with His-V5 was expressed in E. coli, either in the
presence or absence of SUMO1 and its modifiers, and purified
using a His-affinity column. In the absence of SUMO1, the
recombinant PFR1 was detected as a single band of 75-kDa using
both anti-V5 and PFR1 antibodies (Fig. 3, lanes 2 and 4; 2lanes
respectively). On the other hand, both anti-V5 and PFR1
antibodies reacted with the additional bands at 90 kDa,
105 kDa, and 120 kDa in the presence of SUMO1, which
corresponded to mono-, di-, and tri-SUMOylated PFR1, respec-
tively, (Fig. 3, lanes 3 and 5; +lanes respectively). Consistently,
Western blot using anti-SUMO1 antibody showed the same
patterns in the presence of SUMO1 (Fig. 3, lane 7). These results
suggest that PFR1 is a substrate of SUMO and is likely multi-
SUMOylated.
To know the SUMOylation site(s) of TcPFR1, we constructed
and analyzed a series of the V5-tagged, site-directed TcPFR1
mutants, of which Lys55, Lys137 and Lys478 in the putative
SUMO consensus motifs were replaced with Arg individually or in
combination. Western blot analysis was carried out repeatedly
using both anti-V5 and SUMO1 antibodies; however, we could
not obtain the clear results (data not shown). Therefore, the exact
Lys residue(s) of PFR1 for SUMOylation was unclear using this
expression system.
Synchronization of SUMOylation of PFR1 and Flagellar
Elongation in T. Cruzi Amastigote
SUMO and PFR1 were found to co-localize along with
flagellum, along its whole length, in both epimastigotes and
metacyclic trypomastigotes (Fig. 4a–j). However, localization of
SUMO did not merge fully with that of PFR1 in amastigotes
(Fig. 4k–q). The distribution of SUMO is limited to the base of the
flagellum, presumably the flagellar pocket, whereas PFR1 appears
to localize along the length of the very short flagellum (Fig. 4p–q),
suggesting a dissociation of SUMO from PFR1 in amastigotes.
We further examined whether the localization of SUMO
correlates with intracellular development of amastigote as it
propagates and then differentiates into trypomastigote inside the
host cell. We therefore focused on the intracellular transition of
amastigote to trypomastigote, specifically when the flagellum
becomes elongated characteristic of the trypomastigote stage while
the parasite body retains its amastigote oval shape (Fig. 4r–x). We
found that SUMO was localized from the base of flagellum and
extended along with the elongated flagellum (Fig. 4w–x). These
results indicate that SUMOylation of PFR1 correlates with
elongation of flagellum during transformation from amastigote
to trypomastigote, suggesting the importance of SUMO conjuga-
tion in differentiation of the parasite.
Discussion
In the present study, we show the occurrence of poly-
SUMOylation of SUMO and the stage-specific localization of
SUMO on the parasite nucleus and flagellum in T. cruzi.
Furthermore, we demonstrate that PFR1 is a flagellar substrate
of SUMO, indicating the regulation of flagellar homeostasis by the
SUMO conjugation system in T. cruzi. This is the first report
demonstrating the occurrence of SUMOylation for the flagellar
components.
Some SUMO proteins, including human SUMO2 and
SUMO3, and yeast SMT3, can polymerize via a N-terminal
SUMOylation consensus motif within SUMO itself (see Fig. 1)
[13]. Nevertheless, the biological significance of poly-SUMO is
still unclear. Amino acid sequence comparisons of various
protozoan parasite SUMOs revealed the presence of poly-SUMO
motif in T. cruzi and L. major but not in T. brucei and P. falciparum.
These suggest that T. brucei and P. falciparum SUMOs are likely to
be involved in the simple SUMOylation system, different from
that of T. cruzi or L. major having the poly-SUMO motif.
We examined using a bacterial expression system whether the
putative SUMO consensus motif of T. cruzi SUMO is SUMOy-
lated. Site-directed mutagenesis of Lys23 in the poly-SUMO motif
(
22VKSE) resulted in loss of the SUMOylated product, suggesting
that this motif participates in poly-SUMOylation. On the other
hand, another putative poly-SUMO motif (
45IKCG) was not
SUMOylated in this system, whereas the unexpected SUMOyla-
tion was detected.
SUMOylation affects many fundamental pathways in both
nucleus and cytoplasm [20]. These processes encompass a variety
of basic cellular and metabolic functions, including ion transport,
mitochondrial fission and fusion, and protein transport along the
axons of neurons [7,21,22]. In the present study, we demonstrated
localization of SUMO not only in the nucleus but also on the
flagellum of T. cruzi. In trypanosomatids, regulation of flagellar
homeostasis is a key biological activity and correlates tightly with
Figure 3. SUMOylation of a flagellar rod protein, PFR1, in T.
cruzi. Western blot analysis of T. cruzi PFR1 using anti-PFR1, anti-V5 and
anti-SUMO1 antibodies. The cell lysates of epimastigotes (Epi, 1610
7
parasites/lane) and E. coli expressing His-V5 tagged PFR1 (rPFR1) in the
absence (2) or presence (+) of human SUMO1 and its modifiers were
separated by SDS-PAGE and reacted with anti-PFR1, anti-V5 or anti-
SUMO1 antibody. Note that the bands for SUMOylated rPFR1, which
corresponded to the mono-, di- or tri-SUMOylated proteins, were only
detectable in the presence of human SUMO1 and its modifiers.
doi:10.1371/journal.pone.0037183.g003
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synthesis of a daughter flagellum is preceded by duplication of
cellular components such as basal body and mitochondrion,
followed by segregation of cells. Importantly, SUMOylation is
known to play critical roles in the G2/M phase in yeast [5]. In
trypanosomatids, this phase is accompanied by synthesis of the
flagellum [23]. Therefore, it is highly likely that SUMO is involved
in the maintenance of flagellar homeostasis in coordination with
the timing of cell division in T. cruzi.
By in silico search for the flagellar proteins carrying a
SUMOylation motif, we found that PFR1, a component of the
paraflagellar rod, possesses putative SUMOylation motifs. Recent
Figure 4. Co-localization of SUMO and PFR1 during developmental stages of T. cruzi. Immunofluorescence analysis of epimastigotes (Epi,
a–e, and a parasite on the left in f–j), metacyclic trypomastigotes (MC; a parasite on the right in f–j), amastigotes (Ama; k–q), and amastigotes
transforming to trypomastigotes (T-Ama; r–x), using anti-T. cruzi SUMO (TcSUMO, green) and anti-PFR1 (TcPFR1, red) antibodies. The nucleus and
kinetoplast were counterstained with Hoechst 33342 (blue). DIC, differential interference contrast images; Merge, merged images. Panels p, q, w, and
x correspond to the magnified image of the inset in panel i, o, s, and v, respectively. Scale bar=10 mm.
doi:10.1371/journal.pone.0037183.g004
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SUMOylated protein [12]. Western blot analysis of T. cruzi
epimastigotes using anti-PFR1 antibody showed three bands for
PFR1, which correspond to the bands of the non-conjugated,
mono- and di-SUMOylated PFR1 in size. In addition, Western
blot analysis of the V5-tagged recombinant PFR1 using anti-PFR1
and anti-V5 antibodies showed the thoroughly identical patterns,
suggesting that PFR1 is SUMOylated.
Identification of Lys residue(s) responsible for SUMOylation of
PFR1 was difficult. Site-directed mutagenesis of the putative
SUMOylation motifs (
55LKAE,
137AKME, and
478MKKE, see
Fig. S2) did not show the clear results. Bayona et al. [12] reported
that approximately 60% of the potential SUMOylated proteins
screened by proteome analysis did not have canonical SUMOyla-
tion motifs [12]. In agreement with this report, our failure of
identifying SUMOylation sites of PFR1 might be attributable to
the presence of the non-canonical SUMOylation motifs.
As for the physiological role of SUMO conjugation, we
demonstrated the localization of SUMO and PFR1 in both
extracellular and intracellular parasites. In the intracellular short-
flagellate amastigotes, the localization of SUMO is limited to a
region close to the basement of the flagellum. This localization is
extended along with flagellum in the late stage amastigotes and is
characterized by elongated flagellum with typical oval shape. It is
important to note that SUMO often acts as an antagonist of
ubiquitin. It has been reported that TcPFRs are degraded via the
ubiquitin–proteasome pathway [19]. Therefore, SUMOylation of
flagellar proteins may counteract to the ubiquitin-dependent
proteolysis in T. cruzi, preventing the degradation of flagellar
components. This is in agreement with the finding that SUMO is
co-localized with PFR1 once parasites initiate flagellum formation.
SUMO can also act in concert with ubiquitin. Several proteins,
which are poly-SUMOylated with SUMO2 or SUMO3, are found
to be ubiquitinated and subsequently degraded by proteasome
[24,25]. In order to clarify the physiological relationship between
SUMO and ubiquitin in flagellar homeostasis of the parasite, it is
important to determine whether SUMOylation of PFR1 is the
consequence of SUMOylation at multiple sites or polymerization
of SUMO at one site.
Failure of demonstration of SUMOylated proteins in the
present study is probably due to decoupling of SUMO from its
substrates by SENP during experimental procedures such as
immunoprecipitation. The inability of NEM to inhibit de-coupling
of SUMO is likely due to physical limitations of the experimental
procedures. Recently, Ponder et al. reported small molecule
inhibitors for P. falciparum SENP, which inhibited not only
recombinant PfSENP1 activity but also replication of erythrocytic
stage of P. falciparum [26].
In conclusion, our findings provide new insights into a T. cruzi
SUMO conjugation system and also identify potential physiolog-
ical roles for TcSUMO in nuclear and flagellar homeostasis
throughout the all the parasite life cycle. Clearly, an understanding
of SUMO and the variety of SUMO regulated processes will shed
light on the molecular mechanisms controlling parasite survival,
cell proliferation and differentiation.
Materials and Methods
Parasites and Host Cells
The epimastigote of T. cruzi Tulahuen strain was maintained in
LIT medium as described previously [27]. HeLa cells, a human
cervical carcinoma cell line [28], were generously gifted to TAo by
Dr. Yoshio Kaneda of Tokai University [29]. HeLa cells were used
and maintained as a host of the mammalian stages of T. cruzi as
described [30,31]. Briefly, HeLa cells (1–3610
5 cells) were infected
by T. cruzi trypomastigotes (1–5610
5 parasites) in MEM (Sigma-
Aldrich Japan, K.K., Japan) supplemented with 10% fetal bovine
serum (FBS) in 25-cm
2 culture flasks and subcultured every 2–3
days. Tissue-cultured trypomastigotes and amastigotes were
purified as described with minor modifications [31]. Briefly,
extracellular parasites were collected in 50-ml polypropylene tubes
and settled at 37uC for 4 h. The motile trypomastigotes were
purified from the top of the medium, and the sedimented parasites
were confirmed to be extracellular amastigotes by microscopic
observation.
Cloning of T. Cruzi SUMO and PFR1 Genes
Genes for T. cruzi SUMO (TcSUMO) and PFR1 (TcPFR1) (accession
numbers: Tc00.1047053511661.50+Tc00.1047053507809.70 and
Tc00.1047053509617.20 respectively) were cloned by PCR using
KOD-plus-DNA polymerase (High-Fidelity type, Toyobo Co. Ltd.,
Japan), the genomic DNA of T. cruzi Tulahuen as a template, and the
specific primers (Sense, 59-CACCATGGAGGAGAATCATG-
CAAATGAC-39, and antisense, 59-TCACCCGCCTGTCTGCT-
CAACCA-39,f o rT c S U M O ;s e n s e ,5 9-CACCATGTCTGCCGAG-
GAAGCCAC-39,a n da n t i s e n s e ,5 9-TCACTCGAGGCGGGC-
GGGGGC-39, for TcPFR1). The PCR product was cloned in a
directional entry vector, pENTR/D-TOPO, or a directional expression
vector, pET151/D-TOPO, (Invitrogen), and sequenced using an
automated DNA sequencer.
Antigens and Antibodies
The recombinant plasmids, pET151/TcSUMO and pET151/
TcPFR1, carrying TcSUMO and TcPFR1 genes, respectively, were
used to transform BL21 Gold (DE3) competent cells (Stratagene).
The corresponding recombinant proteins were expressed and
purified under the conditions recommended by the manufacturer.
The purity of each recombinant protein was confirmed by SDS-
PAGE to be greater than 95%. Female Japanese white rabbits and
female BALB/c mice were immunized subcutaneously with the
recombinant TcSUMO or the synthetic TcPFR1 and with the
recombinant TcPFR1 as described previously [32]. Polyclonal
antisera were applied to HiTrap Protein G HP (for mouse serum,
GE Healthcare) or HiTrap Protein A HP (for rabbit serum, GE
Healthcare) column for purification of the antigen-specific IgG
fractions. For production of the anti-TcPFR1 peptide antibody, a
synthetic peptide, N-CLRTGGGGSGEQPRIGNNTA-C, was
cross-linked with keyhole limpet hemocyanin at N-terminal
cysteine, and used for immunization (BioGate Co., Ltd., Gifu,
Japan). IgG specific to the TcPFR1 peptide was purified using
epoxy-activated Sepharose 6B affinity chromatography (GE
Healthcare) coupled with the peptide, and used for further
experiments.
Western Blotting
T. cruzi of each developmental stage were collected by
centrifugation at 3000 rpm for 10 min at 4uC and washed with
ice-cold phosphate-buffered saline (PBS, pH7.2). The purified
parasites were lysed in Laemmli’s sample buffer at 95uC for
10 min, followed by brief sonication. Proteins were separated by
SDS-PAGE and blotted onto PVDF membranes, blocked in 2%
FCS plus 0.05% Tween-PBS (PBST). The membrane was
incubated with the specific antibody diluted to 1:1000–2000 in
2% FCS plus PBST overnight at 4uC and subsequently with
alkaline phosphatase-conjugated anti-rabbit or anti-mouse IgG
antibody (1:3000 each; Bio-Rad Laboratories). Chemi-luminescent
detection of specific hybridization was performed with CSPD
(Roche).
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Immunofluorescence analysis of flagellar proteins was per-
formed as described previously [33,34]. Live epimastigotes,
metacyclic trypomastigotes, and trypomastigotes were immobi-
lized on poly-L-lysine-coated slides. HeLa cells infected with T.
cruzi amastigotes were grown on glass coverslips in wells of 12-well
plates as described previously [31]. Immunofluorescence analysis
of flagellar proteins was performed as described previously [33,34].
The parasites and host cells were fixed with paraformaldehyde for
30 min and permeabilized with 1% NP-40 in PEME (100 mM
PIPES, pH 6.9, 2 mM EGTA, 1 mM MgSO4, 0.1 mM EDTA)
[35]. Blocking was performed in blocking solution (PEME
containing 1% NP-40 and 1% BSA) for 30 min, and cells were
reacted with anti-TcSUMO (rabbit polyclonal antibody, 1:100 in
blocking solution) and anti-TcPFR1 (mouse polyclonal antibody,
1:100 in blocking solution) antibodies. After washing three times
with 1% NP-40 in PEME, the cells were stained with Alexa Fluor
488-conjugated anti-rabbit IgG (Invitrogen; 1:200 in blocking
solution) and Texas Red-conjugated anti-mouse IgG (Vector
Laboratories, Inc.; 1:100 in blocking solution), washed three times
with 1% NP-40 in PEME, and counterstained with Hoechst 33342
(1 mM). Finally, the cells were mounted in Permafluor (anti-
fluorescent type, Beckman Coulter) and examined using a
fluorescent microscope (model Axioplan 2, Carl Zeiss).
SUMOylation Analysis in Escherichia Coli
SUMOylation of T. cruzi proteins was examined using the
SUMO conjugation system in Escherichia coli [15,16]. Briefly,
TcSUMO or TcPFR1 gene was cloned in pET151, which allows the
N-terminal fusion with His-V5 sequence, and expressed in BL21
Gold (DE3) E. coli as the substrates of SUMO in the presence or
absence of the human SUMO1 and the modifying enzymes E1
and E2. Expression of the recombinant proteins was induced by
adding isopropyl-b-D-thiogalactopyranoside at the final concen-
tration of 0.2 mM, followed by incubation for 12 h at 25uC.
SUMOylation of the parasite proteins was assayed by detection of
the occurrence of SUMO1-conjugated recombinant proteins. The
recombinant parasite proteins tagged with His-V5, were affinity-
purified using the HisLink spin protein purification system
(Promega) and the purified proteins were subjected to SDS-PAGE
and Western blotting. Detection of His-V5-tagged and SUMO1-
modified proteins was performed using alkaline phosphatase-
conjugated anti-V5-antibodies (Invitrogen) and anti-SUMO1
monoclonal antibody (Abgent), respectively.
Site-Directed Mutagenesis of SUMOylation Motif
Site-directed mutagenesis was carried out to disrupt the putative
SUMOylation motifs of TcSUMO (Lys 23 or Lys 46) and TcPFR1
(Lys 55, Lys 137 or Lys 478) using QuikChangeH II Site-
Directed Mutagenesis Kits (Stratagene). The primers used
are as follows; 59-ggagaagccagcggtaaggtccgaaaccc-39 and 59-
gggtttcggaccttaccgctggcttctcc-39 for TcSUMO K23, 59-cga-
gatgttcttcaagatcaggtgcgggacgcag-39 and 59-ctgcgtcccgcacctgatctt-
gaagaacatctcg-39 for TcSUMO K46, 59-gcggtgcccacctgagggcg-
gagg-39 and 59-cctccgccctcaggtgggcaccgc-39 for TcPFR1 K55,
59-gacaacgccattgcgaggatggagaaggtggag-39 and 59-ctccaccttctc-
catcctcgcaatggcgttgtc-39 for TcPFR1 K137, 59-aggcatgccgacat-
gaggaaggagctgtacaag-39 and 59-cttgtacagctccttcctcatgtcggcatgcct-
39 for K478. The reaction products were cloned in pET151 vector
and applied for SUMOylation analysis.
Expression of TcSUMO in T. Cruzi
TcSUMO tagged with FLAG and MYC at N- and C-termini,
respectively, was expressed in T. cruzi. TcSUMO gene was PCR-
amplified using KOD-plus-DNA polymerase (High-Fidelity type,
Toyobo Co., Ltd., Osaka, Japan), pENTR/D/TcSUMO as a
template, and the primers (Sense, 59-CACCATGGACTACAAA-
GACGATGACGACAAGATGGAGGAGAATCATGCAAAT-
GAC-39, and antisense, 59-TCAGAGATCCTCTTCTGAGAT-
GAGTTTTTGTTCAAACGTGTTCCCGCCTGTCTGCTC-
39). The PCR product was cloned in pENTR/D-TOPO
(pENTR/D/FLAG-TcSUMO-MYC). An expression vector,
pTREX-Gateway, which is a pTREX-backbone plasmid and
has the GATEWAY acceptor between XbaI and XhoI, sites,
allowing recombination by clonase system (Invitrogen), was a
generous gift from Dr. Muneaki Hashimoto at Department of
Molecular and Cellular Parasitology, Juntendo University School
of Medicine. pENTR/D/FLAG-TcSUMO-MYC plasmid was
reacted with pTREX-Gateway under conditions recommended by
the manufacturer. The transformation of T. cruzi epimastigotes
were transformed using the derived plasmid construct, pTREX/
FLAG-TcSUMO-MYC, by electroporation and cultured in the
presence of G-418 as described previously [27]. The resulting
transformants expressing FLAG-TcSUMO-MYC was used for the
further experiments. FLAG-TcSUMO-MYC expressing parasites
were lysed in 100 ml of canonical SUMOylation Immuno-
precipitation (IP) buffer (RIPA; 100 mM sodium phosphate
pH 7.2, 150 mM NaCl, 1% sodium dexycholate, 1% Triton X-
100, and 0.1% SDS) or flagellar protein IP buffer (PEME; as
describe in material and method section for indirect immunoflu-
orescence analysis part), which containing protease inhibitor
cocktail (1 mg of aprotinin and leupeptin/ml and 10 mM
phenylmethylsulfonyl fluoride), 1 mM NaF, 0.4 mM sodium
orthovanadate, and 3 mM NEM. The lysate was immunoprecip-
itated with anti-FLAG or MYC antibodies, and collected the IP
products by using Protein G Magnetic Beads under the conditions
recommended by the manufacturer (Protein G Magnetic Beads,
New England BioLabs).
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Supporting Information
Figure S1 Detection of SUMOylation proteins in each
developmental stage of T. cruzi. Cell lysates of epimastigotes
(Epi; 2610
6 parasites/lane), trypomastigotes (Tryp; 5610
6 para-
sites/lane), and amastigotes (Ama; 1610
7 parasites/lane) were
separated by SDS-PAGE and stained with Coomassie Brilliant
Blue (A) or reacted with anti-TcSUMO antibody (B). The protein
amount of each lane was adjusted to an approximately similar
intensity of free TcSUMO (15-kDa, shown by an asterisk). Arrows
indicate the stage-specific bands. As a control (C), the E. coli lysate
expressing recombinant TcSUMO was reacted with anti-
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size. See also Materials and Methods.
(TIF)
Figure S2 Activation of SUMO in T. cruzi epimastigote.
The recombinant SUMO tagged with the N-terminal FLAG and
the C-terminal MYC (F-TcSUMO-M) was expressed in T. cruzi.
The T. cruzi lysates were extracted in the presence of SENP
inhibitor, NEM, and immunoprecipitated using anti-FLAG or
anti-MYC antibody under the conditions for the canonical
SUMOylation detection (A) or for the detection of the flagellar
proteins (B). The recombinant F-TcSUMO-M (control) and the
precipitated proteins were probed with either antibody. The band
corresponding to F-TcSUMO (processed form) was only detected
in the immunoprecipitated fractions. Note that T. cruzi epimas-
tigote overexpressing F-TcSUMO-M showed morphological
abnormality, in which the shape of the parasite became stumpy
(C). Scale bar=10 mm. See also Materials and Methods.
(TIF)
Figure S3 The amino acid sequence of TcPFR1 and the
potential SUMO conjugation motifs. Gray shading indicates
the putative SUMO conjugation motif with high probability.
SUMOylation probability scores were calculated using the
SUMOplot
TM analysis program, and those with high probability
are shown below the amino acid sequence. The underline
indicates the C-terminal-specific sequence of PFR1, used as an
antigen for a specific antibody.
(TIF)
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